These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resolution of acquired factor X deficiency with amyloidosis secondary to plasma cell dyscrasia. Mohri H Am J Hematol; 2004 Dec; 77(4):421-2. PubMed ID: 15551292 [No Abstract] [Full Text] [Related]
4. Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone. Levin M; Chokas W N Engl J Med; 1987 Oct; 317(18):1155-6. PubMed ID: 3657882 [No Abstract] [Full Text] [Related]
5. Objective response in amyloidosis treated with intermittent chemotherapy. Farhangi M; Thakur VM; Durham JB South Med J; 1984 Jun; 77(6):775-7. PubMed ID: 6729558 [TBL] [Abstract][Full Text] [Related]
6. The successful treatment of primary amyloidosis with intermittent chemotherapy. Bradstock K; Clancy R; Uther J; Basten A; Richards J Aust N Z J Med; 1978 Apr; 8(2):176-9. PubMed ID: 277166 [TBL] [Abstract][Full Text] [Related]
7. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy. Camoriano JK; Greipp PR; Bayer GK; Bowie EJ N Engl J Med; 1987 Apr; 316(18):1133-5. PubMed ID: 3574359 [No Abstract] [Full Text] [Related]
8. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine. Benson MD Arthritis Rheum; 1986 May; 29(5):683-7. PubMed ID: 3718560 [TBL] [Abstract][Full Text] [Related]
9. Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature. Gertz MA; Kyle RA Mayo Clin Proc; 1986 Mar; 61(3):218-23. PubMed ID: 3945122 [TBL] [Abstract][Full Text] [Related]
10. [Therapy options in systemic AL-amyloidosis with renal involvement]. Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of primary amyloidosis with dimethylsulfoxide and cytoreductive chemotherapy. Shibuya T; Murakawa M; Tsuda Y; Harada M Intern Med; 1992 Apr; 31(4):544-8. PubMed ID: 1633367 [TBL] [Abstract][Full Text] [Related]
12. High-dose therapy and autologous transplantation in amyloidosis-AL. Majolino I; Marcenò R; Pecoraro G; Scimé R; Vasta S; Liberti G; Rizzo A; Indovina A; Caronia F Haematologica; 1993; 78(1):68-71. PubMed ID: 8098314 [TBL] [Abstract][Full Text] [Related]
13. A rare complication of monoclonal gammopathy. Nasr SH; Lobritto SJ; Lauring BP; Arend LJ; D'Agati VD; Markowitz GS Am J Kidney Dis; 2002 Oct; 40(4):867-71. PubMed ID: 12324928 [No Abstract] [Full Text] [Related]
15. [Immunomodulatory drugs in the treatment of primary systemic light chain amyloidosis]. Charliński G; Wiater E; Jedrzejczak WW Pol Merkur Lekarski; 2012 Apr; 32(190):217-20. PubMed ID: 22708276 [TBL] [Abstract][Full Text] [Related]
16. Report of 6 cases of large granular lymphocytic leukemia and plasma cell dyscrasia. Cheng J; Talamo G; Malysz J; Ochmann M; Lamy T; Loughran TP Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e169-72. PubMed ID: 25037886 [No Abstract] [Full Text] [Related]
17. Therapy of primary amyloidosis with melphalan and prednisone. Schwartz RS; Cohen JR; Schrier SL Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747 [TBL] [Abstract][Full Text] [Related]
18. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Sanchorawala V; Seldin DC Amyloid; 2007 Dec; 14(4):261-9. PubMed ID: 17968685 [TBL] [Abstract][Full Text] [Related]
19. Resolution of primary amyloidosis by melphalan and prednisolone: a case report. Nakayama M; Kashiwagi M; Katafuchi R; Hori K; Hayashi S; Fujimi S Clin Nephrol; 2005 Mar; 63(3):215-20. PubMed ID: 15786823 [TBL] [Abstract][Full Text] [Related]
20. [Current treatment of AL amyloidosis]. Desport E; Moumas E; Abraham J; Delbès S; Lacotte-Thierry L; Touchard G; Fermand JP; Bridoux F; Jaccard A Nephrol Ther; 2011 Nov; 7(6):467-73. PubMed ID: 21497573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]